Global Osteoarthritis Pain Drugs Market Research Report 2017-2022 by Players, Regions, Product Types & Applications

Published: Aug, 2017 | Pages: 113 | Publisher: Data Market Research (DMR)
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global Osteoarthritis Pain Drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report offers an overview of the market trends, drivers, and barriers with respect to the Osteoarthritis Pain Drugs market. It also provides a detailed overview of the market of different regions across United States, Europe, China, Japan, India, Southeast Asia and Others. The report categorizes Osteoarthritis Pain Drugs market by By Usage Mode, By Form, and application. Detailed analysis of key players, along with key growth strategies adopted by them is also covered in this report on Osteoarthritis Pain Drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report focuses Global market, it covers details as following:

Key Players
    Johnson & Johnson (US)
    Pfizer (US)
    GlaxoSmithKline (UK)
    Mylan (US)
    Lilly (US)
    Sanofi (France)
    Abbott Laboratories (US)
    Bayer (Germany)
    Almatica Pharma (US)
    Teva Pharmaceutical Industries (Israel)
    Iroko Pharmaceuticals (US)

Key Regions
    North America
        United States
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main types of products
Osteoarthritis Pain Drugs Market, by Usage Mode
    Oral
    Injection
    External
Osteoarthritis Pain Drugs Market, by Form
    Tablets
    Ointment
    Spray

Osteoarthritis Pain Drugs Market, by Key Consumer
    Medical Care
    Personal Care
    Other

 Table of Contents

Global Osteoarthritis Pain Drugs Market Research Report 2017-2022 by Players, Regions, Product Types & Applications
Chapter One Methodology and Data Source
    1.1 Methodology/Research Approach
        1.1.1 Research Programs/Design
        1.1.2 Market Size Estimation
        1.1.3 Market Breakdown and Data Triangulation
    1.2 Data Source
        1.2.1 Secondary Sources
        1.2.2 Primary Sources
    1.3 Disclaimer

Chapter Two Osteoarthritis Pain Drugs Market Overview
    2.1 Market Coverage
    2.2 Global Osteoarthritis Pain Drugs Market Sales Volume Revenue and Price 2012-2017

Chapter Three Osteoarthritis Pain Drugs by Key Players 2012-2017
    3.1 Global Osteoarthritis Pain Drugs Sales Volume Market Share by Key Players 2012-2017
    3.2 Global Osteoarthritis Pain Drugs Revenue Share by Key Players 2012-2017
    3.3 Global Key Players Osteoarthritis Pain Drugs Key Product Model and Market Performance
    3.4 Global Key Players Osteoarthritis Pain Drugs Key Target Consumers and Market Performance

Chapter Four Osteoarthritis Pain Drugs by Regions 2012-2017
    4.1 Global Osteoarthritis Pain Drugs Sales Market Share by Regions 2012-2017
    4.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Regions 2012-2017
    4.3 Global Osteoarthritis Pain Drugs Price by Regions 2012-2017
    4.4 North America
        4.4.1 United States
        4.4.2 Canada
    4.5 Latin America
        4.5.1 Mexico
        4.5.2 Brazil
        4.5.3 Argentina
        4.5.4 Others in Latin America
    4.6 Europe
        4.6.1 Germany
        4.6.2 United Kingdom
        4.6.3 France
        4.6.4 Italy
        4.6.5 Spain
        4.6.6 Russia
        4.6.7 Netherland
        4.6.8 Others in Europe
    4.7 Asia & Pacific
        4.7.1 China
        4.7.2 Japan
        4.7.3 India
        4.7.4 Korea
        4.7.5 Australia
        4.7.6 Southeast Asia
            4.7.6.1 Indonesia
            4.7.6.2 Thailand
            4.7.6.3 Philippines
            4.7.6.4 Vietnam
            4.7.6.5 Singapore
            4.7.6.6 Malaysia
            4.7.6.7 Others in Southeast Asia
    4.8 Africa & Middle East
        4.8.1 South Africa
        4.8.2 Egypt
        4.8.3 Turkey
        4.8.4 Saudi Arabia
        4.8.5 Iran
        4.8.6 Others in Africa & Middle East

Chapter Five Osteoarthritis Pain Drugs Market by Product Types
    5.1 Osteoarthritis Pain Drugs, by Usage Mode 2012-2017
        5.1.1 Global Osteoarthritis Pain Drugs Sales Market Share by Usage Mode 2012-2017
        5.1.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Usage Mode 2012-2017
        5.1.3 Global Osteoarthritis Pain Drugs Price by Usage Mode 2012-2017
        5.1.4 Oral
        5.1.5 Injection
        5.1.6 External
    5.2 Osteoarthritis Pain Drugs, by Form 2012-2017
        5.2.1 Global Osteoarthritis Pain Drugs Sales Market Share by Form 2012-2017
        5.2.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Form 2012-2017
        5.2.3 Global Osteoarthritis Pain Drugs Price by Form 2012-2017
        5.2.4 Tablets
        5.2.5 Ointment
        5.2.6 Spray

Chapter Six Global Key Players Profile
    6.1 Johnson & Johnson (US)
        6.1.1 Johnson & Johnson (US) Company Details and Competitors
        6.1.2 Johnson & Johnson (US) Key Osteoarthritis Pain Drugs Models and Performance
        6.1.3 Johnson & Johnson (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        6.1.4 Johnson & Johnson (US) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.2 Pfizer (US)
        6.2.1 Pfizer (US) Company Details and Competitors
        6.2.2 Pfizer (US) Key Osteoarthritis Pain Drugs Models and Performance
        6.2.3 Pfizer (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        6.2.4 Pfizer (US) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.3 GlaxoSmithKline (UK)
        6.3.1 GlaxoSmithKline (UK) Company Details and Competitors
        6.3.2 GlaxoSmithKline (UK) Key Osteoarthritis Pain Drugs Models and Performance
        6.3.3 GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        6.3.4 GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.4 Mylan (US)
        6.4.1 Mylan (US) Company Details and Competitors
        6.4.2 Mylan (US) Key Osteoarthritis Pain Drugs Models and Performance
        6.4.3 Mylan (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        6.4.4 Mylan (US) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.5 Lilly (US)
        6.5.1 Lilly (US) Company Details and Competitors
        6.5.2 Lilly (US) Key Osteoarthritis Pain Drugs Models and Performance
        6.5.3 Lilly (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        6.5.4 Lilly (US) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.6 Sanofi (France)
        6.6.1 Sanofi (France) Company Details and Competitors
        6.6.2 Sanofi (France) Key Osteoarthritis Pain Drugs Models and Performance
        6.6.3 Sanofi (France) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        6.6.4 Sanofi (France) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.7 Abbott Laboratories (US)
        6.7.1 Abbott Laboratories (US) Company Details and Competitors
        6.7.2 Abbott Laboratories (US) Key Osteoarthritis Pain Drugs Models and Performance
        6.7.3 Abbott Laboratories (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        6.7.4 Abbott Laboratories (US) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.8 Bayer (Germany)
        6.8.1 Bayer (Germany) Company Details and Competitors
        6.8.2 Bayer (Germany) Key Osteoarthritis Pain Drugs Models and Performance
        6.8.3 Bayer (Germany) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        6.8.4 Bayer (Germany) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.9 Almatica Pharma (US)
        6.9.1 Almatica Pharma (US) Company Details and Competitors
        6.9.2 Almatica Pharma (US) Key Osteoarthritis Pain Drugs Models and Performance
        6.9.3 Almatica Pharma (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        6.9.4 Almatica Pharma (US) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.10 Teva Pharmaceutical Industries (Israel)
        6.10.1 Teva Pharmaceutical Industries (Israel) Company Details and Competitors
        6.10.2 Teva Pharmaceutical Industries (Israel) Key Osteoarthritis Pain Drugs Models and Performance
        6.10.3 Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
        6.10.4 Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Sales Volume Revenue Price Cost and Gross Margin
    6.11 Iroko Pharmaceuticals (US)

Chapter Seven Osteoarthritis Pain Drugs by Appliance 2012-2017
    7.1 Global Osteoarthritis Pain Drugs Sales Market Share by Appliance 2012-2017
    7.2 Medical Care
    7.3 Personal Care
    7.4 Other
    7.5 Consuming Habit and Preference

Chapter Eight Industry Chain and Supply Chain
    8.1 Osteoarthritis Pain Drugs Industry Chain Structure
        8.1.1 R&D
        8.1.2 Raw Materials (Components)
        8.1.3 Manufacturing Plants
        8.1.4 Regional Trading (Import Export and Local Sales)
        8.1.5 Online Sales Channel
        8.1.6 Offline Channel
        8.1.7 End Users
    8.2 Osteoarthritis Pain Drugs Manufacturing
        8.2.1 Key Components
        8.2.2 Assembly Manufacturing
    8.3 Consumer Preference
    8.4 Behavioral Habits
    8.5 Marketing Environment

Chapter Nine Global Osteoarthritis Pain Drugs Market Size (Sales and Revenue) Forecast (2017-2022)
    9.1 Global Osteoarthritis Pain Drugs Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    9.2 Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Regions (2017-2022)
    9.3 Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Application (2017-2022)
    9.4 Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Usage Mode (2017-2022)
    9.5 Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Form (2017-2022)

Chapter Ten Development Trend and Research Conclusion
    10.1 Development Trend
    10.2 Research Conclusion

List of Tables and Figures

    Table Global Osteoarthritis Pain Drugs Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
    Figure Global Osteoarthritis Pain Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales Volume (K Pcs) by Key Players (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales Volume Market Share by Key Players (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share by Key Players 2016
    Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share by Key Players 2017
    Table Global Osteoarthritis Pain Drugs Revenue (Million USD) by Key Players (2012-2017)
    Table Global Osteoarthritis Pain Drugs Revenue Market Share by Key Players (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Key Players 2016
    Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Key Players 2017
    Table Global Key Players Key Product Model and Market Performance
    Table Global Key Players Key Target Consumers and Market Performance
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales Share by Regions (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales Market Share by Regions in 2016
    Figure Global Osteoarthritis Pain Drugs Sales Market Share by Regions in 2017
    Table Global Osteoarthritis Pain Drugs Revenue (Million USD) by Regions (2012-2017)
    Table Global Osteoarthritis Pain Drugs Revenue Market Share by Regions (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Regions in 2016
    Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Regions in 2017
    Table Global Osteoarthritis Pain Drugs Price (USD/Pcs) by Regions (2012-2017)
    Table North America Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
    Table North America Osteoarthritis Pain Drugs Revenue (Million USD) by Regions (2012-2017)
    Table North America Osteoarthritis Pain Drugs Sales Volume (K Pcs) by Key Players 2012-2017
    Figure North America Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Latin America Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
    Table Latin America Osteoarthritis Pain Drugs Revenue (Million USD) by Regions (2012-2017)
    Table Latin America Osteoarthritis Pain Drugs Sales Volume (K Pcs) by Key Players (2012-2017)
    Figure Latin America Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Revenue (Million USD) by Regions (2012-2017)
    Table Europe Osteoarthritis Pain Drugs Sales Volume (K Pcs) by Key Players (2012-2017)
    Figure Europe Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Asia & Pacific Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
    Table Asia & Pacific Osteoarthritis Pain Drugs Revenue (Million USD) by Regions (2012-2017)
    Table Asia & Pacific Osteoarthritis Pain Drugs Sales Volume (K Pcs) by Key Players (2012-2017)
    Figure Asia & Pacific Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Africa & Middle East Osteoarthritis Pain Drugs Sales (K Pcs) by Regions (2012-2017)
    Table Africa & Middle East Osteoarthritis Pain Drugs Revenue (Million USD) by Regions (2012-2017)
    Table Africa & Middle East Osteoarthritis Pain Drugs Sales Volume (K Pcs) by Key Players (2012-2017)
    Figure Africa & Middle East Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) by Usage Mode (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales Market Share by Usage Mode (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales Market Share by Usage Mode in 2016
    Table Global Osteoarthritis Pain Drugs Revenue (Million USD) by Usage Mode (2012-2017)
    Table Global Osteoarthritis Pain Drugs Revenue Market Share by Usage Mode (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Usage Mode in 2016
    Table Global Osteoarthritis Pain Drugs Price (USD/Pcs) by Usage Mode (2012-2017)
    Table Top Players of Oral Osteoarthritis Pain Drugs Products List
    Figure Global Oral Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Injection Osteoarthritis Pain Drugs Products List
    Figure Global Injection Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of External Osteoarthritis Pain Drugs Products List
    Figure Global External Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) by Form (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales Market Share by Form (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales Market Share by Form in 2016
    Table Global Osteoarthritis Pain Drugs Revenue (Million USD) by Form (2012-2017)
    Table Global Osteoarthritis Pain Drugs Revenue Market Share by Form (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Form in 2016
    Table Global Osteoarthritis Pain Drugs Price (USD/Pcs) by Form (2012-2017)
    Table Top Players of Tablets Osteoarthritis Pain Drugs Products List
    Figure Global Tablets Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Ointment Osteoarthritis Pain Drugs Products List
    Figure Global Ointment Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Spray Osteoarthritis Pain Drugs Products List
    Figure Global Spray Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) by  (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales Market Share by  (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales Market Share by  in 2016
    Table Global Osteoarthritis Pain Drugs Revenue (Million USD) by  (2012-2017)
    Table Global Osteoarthritis Pain Drugs Revenue Market Share by  (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Revenue Market Share by  in 2016
    Table Global Osteoarthritis Pain Drugs Price (USD/Pcs) by  (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) by  (2012-2017)
    Table Global Osteoarthritis Pain Drugs Sales Market Share by  (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales Market Share by  in 2016
    Table Global Osteoarthritis Pain Drugs Revenue (Million USD) by  (2012-2017)
    Table Global Osteoarthritis Pain Drugs Revenue Market Share by  (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Revenue Market Share by  in 2016
    Table Global Osteoarthritis Pain Drugs Price (USD/Pcs) by  (2012-2017)
    Table Johnson & Johnson (US) Company Details and Competitors
    Table Johnson & Johnson (US) Key Osteoarthritis Pain Drugs Models and Performance
    Table Johnson & Johnson (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table Johnson & Johnson (US) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Johnson & Johnson (US) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Johnson & Johnson (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure Johnson & Johnson (US) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Johnson & Johnson (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table Pfizer (US) Company Details and Competitors
    Table Pfizer (US) Key Osteoarthritis Pain Drugs Models and Performance
    Table Pfizer (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table Pfizer (US) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Pfizer (US) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Pfizer (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure Pfizer (US) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Pfizer (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table GlaxoSmithKline (UK) Company Details and Competitors
    Table GlaxoSmithKline (UK) Key Osteoarthritis Pain Drugs Models and Performance
    Table GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure GlaxoSmithKline (UK) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table Mylan (US) Company Details and Competitors
    Table Mylan (US) Key Osteoarthritis Pain Drugs Models and Performance
    Table Mylan (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table Mylan (US) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Mylan (US) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Mylan (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure Mylan (US) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Mylan (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table Lilly (US) Company Details and Competitors
    Table Lilly (US) Key Osteoarthritis Pain Drugs Models and Performance
    Table Lilly (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table Lilly (US) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Lilly (US) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Lilly (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure Lilly (US) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Lilly (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table Sanofi (France) Company Details and Competitors
    Table Sanofi (France) Key Osteoarthritis Pain Drugs Models and Performance
    Table Sanofi (France) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table Sanofi (France) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Sanofi (France) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Sanofi (France) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure Sanofi (France) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Sanofi (France) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table Abbott Laboratories (US) Company Details and Competitors
    Table Abbott Laboratories (US) Key Osteoarthritis Pain Drugs Models and Performance
    Table Abbott Laboratories (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table Abbott Laboratories (US) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Abbott Laboratories (US) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Abbott Laboratories (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure Abbott Laboratories (US) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Abbott Laboratories (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table Bayer (Germany) Company Details and Competitors
    Table Bayer (Germany) Key Osteoarthritis Pain Drugs Models and Performance
    Table Bayer (Germany) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table Bayer (Germany) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Bayer (Germany) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Bayer (Germany) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure Bayer (Germany) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Bayer (Germany) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table Almatica Pharma (US) Company Details and Competitors
    Table Almatica Pharma (US) Key Osteoarthritis Pain Drugs Models and Performance
    Table Almatica Pharma (US) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table Almatica Pharma (US) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Almatica Pharma (US) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Almatica Pharma (US) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure Almatica Pharma (US) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Almatica Pharma (US) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table Teva Pharmaceutical Industries (Israel) Company Details and Competitors
    Table Teva Pharmaceutical Industries (Israel) Key Osteoarthritis Pain Drugs Models and Performance
    Table Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Business SWOT Analysis and Forecast
    Table Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Sales Market Share (%) in Global (2012-2017)
    Figure Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Teva Pharmaceutical Industries (Israel) Osteoarthritis Pain Drugs Revenue Market Share (%) in Global (2012-2017)
    Table Iroko Pharmaceuticals (US) Company Details and Competitors
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) by Appliance (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales Market Share by Appliance (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales Market Share by Appliance in 2016
    Figure Global Medical Care Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Personal Care Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Other Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Osteoarthritis Pain Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Regions (2017-2022)
    Table Global Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales Volume Share Forecast by Regions in 2022
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Application (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Application in 2022
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Usage Mode (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Usage Mode (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Usage Mode in 2022
    Table Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Form (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales (K Pcs) Forecast by Form (2017-2022)
    Figure Global Osteoarthritis Pain Drugs Sales Volume Market Share Forecast by Form in 2022